大葉大學圖書館 |

Risk regulation in the single market[electronic resource] :the governance of pharmaceuticals and foodstuffs in the European Union /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
杜威分類號:	344.2404/232
書名/作者:	Risk regulation in the single market : the governance of pharmaceuticals and foodstuffs in the European Union // Sebastian Krapohl.
作者:	Krapohl, Sebastian,
出版者:	Basingstoke [England] ; : Palgrave Macmillan,, 2008.
面頁冊數:	xiii, 225 p. : : ill. ;; 23 cm.
附註:	Originally presented as the author's dissertation (doctoral)--Universitèat Bamberg, 2007.
叢書名:	Palgrave studies in European Union politics
標題:	Food law and legislation - European Union countries.
標題:	Drugs - Law and legislation - European Union countries.
ISBN:	9780230584044
ISBN:	0230584047
書目註:	Includes bibliographical references (p. 195-220) and index.
內容註:	Introduction : the need for a systematic analysis of supranational risk regulation -- Functional pressure and path-dependencies : the emergence and development of supranational regulatory regimes -- Efficiency and legitimacy : the evaluation of supranational regulatory regimes -- From national crises to a strong supranational regime : the developmentof pharmaceutical authorisation in Europe-- A strong regulatory regulatory network : -- The evaluation of the European regulatory regime forpharmaceuticals -- From an early single market to a crisis of consumerconfidence : the development of foodstuff regulation in Europe -- A weak supranational agency : the evaluation of the European regulatory regime for foodstuffs -- A comparison of pharmaceutical and foodstuff regulation in Europe.
摘要、提要註:	Why do the regulatory institutions of the EU look different across similar policy areas? Why do they work with different degrees of success? This book provides a theoretically driven comparisonof two importantareas of EU risk regulation. Whereas the functional demands for supranational risk regulation are similar in pharmaceutical and foodstuff regulation, the efficiency of the two respective regulatory regimes has differed widely during the last 15 years. The EU regulatory regime for pharmaceuticals has managed to establish a single market for highly innovative pharmaceuticals - including b1 sred biotechnology b2 s. In contrast, the single market for foodstuffs was shattered by theBSE crisis, and b1 sgreen biotechnology b2 s - that is, GMOs and Gen-Food - is still highly contested. As this book demonstrates, these differences in the efficiency and legitimacy of EU risk regulation can be traced back tothe different institutional designs of the respective regimes, which in turn result from different developmental paths.
電子資源:	access to fulltext (Palgrave)

Risk regulation in the single market[electronic resource] :the governance of pharmaceuticals and foodstuffs in the European Union /
Krapohl, Sebastian,1978-

Risk regulation in the single marketthe governance of pharmaceuticals and foodstuffs in the European Union /[electronic resource] :Sebastian Krapohl. - Basingstoke [England] ;Palgrave Macmillan,2008. - xiii, 225 p. :ill. ;23 cm. - Palgrave studies in European Union politics.

Originally presented as the author's dissertation (doctoral)--Universitèat Bamberg, 2007.

Includes bibliographical references (p. 195-220) and index.

Introduction : the need for a systematic analysis of supranational risk regulation -- Functional pressure and path-dependencies : the emergence and development of supranational regulatory regimes -- Efficiency and legitimacy : the evaluation of supranational regulatory regimes -- From national crises to a strong supranational regime : the developmentof pharmaceutical authorisation in Europe-- A strong regulatory regulatory network : -- The evaluation of the European regulatory regime forpharmaceuticals -- From an early single market to a crisis of consumerconfidence : the development of foodstuff regulation in Europe -- A weak supranational agency : the evaluation of the European regulatory regime for foodstuffs -- A comparison of pharmaceutical and foodstuff regulation in Europe.

Why do the regulatory institutions of the EU look different across similar policy areas? Why do they work with different degrees of success? This book provides a theoretically driven comparisonof two importantareas of EU risk regulation. Whereas the functional demands for supranational risk regulation are similar in pharmaceutical and foodstuff regulation, the efficiency of the two respective regulatory regimes has differed widely during the last 15 years. The EU regulatory regime for pharmaceuticals has managed to establish a single market for highly innovative pharmaceuticals - including b1 sred biotechnology b2 s. In contrast, the single market for foodstuffs was shattered by theBSE crisis, and b1 sgreen biotechnology b2 s - that is, GMOs and Gen-Food - is still highly contested. As this book demonstrates, these differences in the efficiency and legitimacy of EU risk regulation can be traced back tothe different institutional designs of the respective regimes, which in turn result from different developmental paths.

Electronic reproduction.
Basingstoke, England :
Palgrave Macmillan,
2009.

Mode of access:World Wide Web.

ISBN: 9780230584044

Standard No.: 10.1057/9780230584044doiSubjects--Topical Terms:

378850
Food law and legislation
--European Union countries.Index Terms--Genre/Form:

336502
Electronic books.

LC Class. No.: KJE6778 / .K73 2008eb

Dewey Class. No.: 344.2404/232

Risk regulation in the single market[electronic resource] :the governance of pharmaceuticals and foodstuffs in the European Union /
LDR:03360nam 2200337Ia 4500 001 329432
003 OCoLC
005 20100709081748.0
006 m d
007 cr cn|
008 110607s2008 enka sb 001 0 eng d
020 $a 9780230584044
020 $a 0230584047
024 7 $a 10.1057/9780230584044 $2 doi
035 $a (OCoLC)314828560
035 $a ocn314828560
040 $a UKPGM $b eng $c UKPGM
043 $a e------
049 $a APTA
050 1 4 $a KJE6778 $b .K73 2008eb
082 0 4 $a 344.2404/232 $2 22
100 1 $a Krapohl, Sebastian, $d 1978- $3 378849
245 1 0 $a Risk regulation in the single market $h [electronic resource] : $b the governance of pharmaceuticals and foodstuffs in the European Union / $c Sebastian Krapohl.
260 $a Basingstoke [England] ; $a New York : $b Palgrave Macmillan, $c 2008.
300 $a xiii, 225 p. : $b ill. ; $c 23 cm.
440 0 $a Palgrave studies in European Union politics
500 $a Originally presented as the author's dissertation (doctoral)--Universitèat Bamberg, 2007.
504 $a Includes bibliographical references (p. 195-220) and index.
505 0 $a Introduction : the need for a systematic analysis of supranational risk regulation -- Functional pressure and path-dependencies : the emergence and development of supranational regulatory regimes -- Efficiency and legitimacy : the evaluation of supranational regulatory regimes -- From national crises to a strong supranational regime : the developmentof pharmaceutical authorisation in Europe-- A strong regulatory regulatory network : -- The evaluation of the European regulatory regime forpharmaceuticals -- From an early single market to a crisis of consumerconfidence : the development of foodstuff regulation in Europe -- A weak supranational agency : the evaluation of the European regulatory regime for foodstuffs -- A comparison of pharmaceutical and foodstuff regulation in Europe.
520 $a Why do the regulatory institutions of the EU look different across similar policy areas? Why do they work with different degrees of success? This book provides a theoretically driven comparisonof two importantareas of EU risk regulation. Whereas the functional demands for supranational risk regulation are similar in pharmaceutical and foodstuff regulation, the efficiency of the two respective regulatory regimes has differed widely during the last 15 years. The EU regulatory regime for pharmaceuticals has managed to establish a single market for highly innovative pharmaceuticals - including b1 sred biotechnology b2 s. In contrast, the single market for foodstuffs was shattered by theBSE crisis, and b1 sgreen biotechnology b2 s - that is, GMOs and Gen-Food - is still highly contested. As this book demonstrates, these differences in the efficiency and legitimacy of EU risk regulation can be traced back tothe different institutional designs of the respective regimes, which in turn result from different developmental paths.
533 $a Electronic reproduction. $b Basingstoke, England : $c Palgrave Macmillan, $d 2009. $n Mode of access:World Wide Web. $n System requirements: Web browser. $n Title from title screen (viewed on Mar. 3, 2009). $n Access may berestricted to users at subscribing institutions.
650 0 $a Food law and legislation $z European Union countries. $3 378850
650 0 $a Drugs $x Law and legislation $z European Union countries. $3 378851
655 7 $a Electronic books. $2 local $3 336502
710 2 $a Palgrave Connect (Online service) $3 370384
776 1 $c Original $z 9780230537651 $z 0230537650 $w (DLC) 2008030198 $w (OCoLC)236082328
856 4 0 $3 Palgrave Connect $u http://www.palgraveconnect.com/doifinder/10.1057/9780230584044 $z access to fulltext (Palgrave)